This settlement is a disgrace. Some of the funds received now go to the stockholders who funded the legal fees. Then when you include the out of pocket legal expenses CYCC paid, the suit probably resulted in a loss.
How can that be? They received 3 million for the litigation and did not use the total amount as of today. So of the 5.5. million there is still enough left for shareholders.
so.. who cares... cycc is focused on getting a drug approved... this clears the path more now..